Published in Anesth Analg on November 01, 1997
Effect of sevoflurane anesthesia on the severity of renal histopathologic changes in rabbits pretreated with gentamicin: A controlled, investigator-blinded, experimental study. Curr Ther Res Clin Exp (2006) 0.80
Comparison between low flow sevoflurane anesthesia and total intravenous anesthesia during intermediate-duration surgery: effects on renal and hepatic toxicity. Hippokratia (2011) 0.79
Effect of sevoflurane on grafted kidney function in renal transplantation. Korean J Anesthesiol (2012) 0.77
No evidence of sevoflurane-induced renal injury in volunteers. Anesth Analg (1998) 0.75
Case report: proximal tubule impairment following volatile anesthetic exposure. Physiol Rep (2015) 0.75
Comparison of the renal safety between carbon dioxide absorbent products under sevoflurane anesthesia: a pilot study. Korean J Anesthesiol (2012) 0.75
Comparative effect of propofol versus sevoflurane on renal ischemia/reperfusion injury after elective open abdominal aortic aneurysm repair. Saudi J Anaesth (2016) 0.75
Comparison of Effects of Low-Flow Sevoflurane and Low-Flow Desflurane Anaesthesia on Renal Functions Using Cystatin C. Turk J Anaesthesiol Reanim (2017) 0.75
Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg (1994) 4.12
Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology (1994) 2.30
Toxicity of compound A in rats. Effect of increasing duration of administration. Anesthesiology (1994) 2.12
What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion (1994) 1.84
Hypothesis: inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites. Anesth Analg (1997) 1.80
Subanesthetic concentrations of desflurane and propofol suppress recall of emotionally charged information. Anesth Analg (1995) 1.75
Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme. Anesth Analg (1995) 1.74
Anesthesia by n-alkanes not consistent with the Meyer-Overton hypothesis: determinations of the solubilities of alkanes in saline and various lipids. Anesth Analg (1993) 1.70
Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell (2001) 1.68
Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg (1997) 1.66
Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg (1991) 1.63
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ (2004) 1.54
Elderly, conscious patients have an accentuated hypotensive response to nitroglycerin. Anesthesiology (1992) 1.53
Molecular properties of the "ideal" inhaled anesthetic: studies of fluorinated methanes, ethanes, propanes, and butanes. Anesth Analg (1994) 1.52
Naturally occurring variability in anesthetic potency among inbred mouse strains. Anesth Analg (2000) 1.51
Absorption and degradation of sevoflurane and isoflurane in a conventional anesthetic circuit. Anesth Analg (1991) 1.48
Rapid atrial pacing for detecting provokable demand ischemia in anesthetized patients. Anesth Analg (1997) 1.41
Detection of intraoperative segmental wall-motion abnormalities by transesophageal echocardiography: the incremental value of additional cross sections in the transverse and longitudinal planes. Anesth Analg (1996) 1.38
Halogenation and anesthetic potency. Anesth Analg (1989) 1.38
A molecular description of how noble gases and nitrogen bind to a model site of anesthetic action. Anesth Analg (1998) 1.31
What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg (1991) 1.28
Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest (1992) 1.28
Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics) Anesth Analg (1998) 1.28
Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia. Mol Pharmacol (1994) 1.28
Blockade of AMPA receptors and volatile anesthetics: reduced anesthetic requirements in GluR2 null mutant mice for loss of the righting reflex and antinociception but not minimum alveolar concentration. Anesthesiology (2001) 1.27
Role of voltage-sensitive receptors in nicotinic transmission. Biophys J (1978) 1.20
No correlation between quantitative electroencephalographic measurements and movement response to noxious stimuli during isoflurane anesthesia in rats. Anesthesiology (1992) 1.15
The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers. Anesth Analg (1998) 1.14
Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg (1997) 1.13
Mouse strain modestly influences minimum alveolar anesthetic concentration and convulsivity of inhaled compounds. Anesth Analg (1999) 1.12
Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology (1991) 1.09
Amelioration of the symptoms of acute mountain sickness by staging and acetazolamide. Aviat Space Environ Med (1976) 1.09
More on the changing indications for transfusion of blood and blood components during anesthesia. Anesthesiology (1996) 1.07
Anesthetic potencies of n-alkanols: results of additivity and solubility studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth Analg (1997) 1.07
Absorbents differ enormously in their capacity to produce compound A and carbon monoxide. Anesth Analg (2000) 1.06
Minimum alveolar concentration of I-653 and isoflurane in pigs: definition of a supramaximal stimulus. Anesth Analg (1988) 1.05
Anesthetic potencies and the unitary theory of narcosis. Anesth Analg (1981) 1.02
Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology (1991) 0.98
The concentration of isoflurane required to suppress learning depends on the type of learning. Anesthesiology (2001) 0.98
Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology (2000) 0.97
The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption. Anesth Analg (1999) 0.96
Nitrous oxide inactivates methionine synthetase in human liver. Anesth Analg (1982) 0.96
Mice tolerant to nitrous oxide are also tolerant to alcohol. J Pharmacol Exp Ther (1980) 0.94
Identification of a 130-kilodalton human biliary concanavalin A binding protein as aminopeptidase N. Gastroenterology (1994) 0.93
Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration. Anesth Analg (1998) 0.93
Critical oxygen delivery in conscious humans is less than 7.3 ml O2 x kg(-1) x min(-1). Anesthesiology (2000) 0.93
Effect of n-alkane kinetics in rats on potency estimations and the Meyer-Overton hypothesis. Anesth Analg (1994) 0.92
Concentrations of desflurane and propofol that suppress response to command in humans. Anesth Analg (1995) 0.91
Nonanesthetics can suppress learning. Anesth Analg (1996) 0.91
Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis. Anesth Analg (1996) 0.91
The electroencephalographic effects of desflurane in humans. Anesthesiology (1991) 0.91
Anaesthetic requirement in mice selectively bred for differences in ethanol sensitivity. Br J Anaesth (1981) 0.90
Acute hypovolemia may cause segmental wall motion abnormalities in the absence of myocardial ischemia. Anesth Analg (1997) 0.90
I653 and isoflurane produce similar dose-related changes in the electroencephalogram of pigs. Anesthesiology (1988) 0.90
Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesth Analg (1991) 0.90
Hematologic effects of nitrous oxide in surgical patients. Anesth Analg (1990) 0.90
Potencies of inhaled anesthetics and alcohol in mice selectively bred for resistance and susceptibility to nitrous oxide anesthesia. Anesthesiology (1982) 0.90
Cardiovascular actions of desflurane in normocarbic volunteers. Anesth Analg (1991) 0.88
Brain monoamines and the high pressure neurological syndrome. Neuropharmacology (1980) 0.88
Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-h exposure, including kinetics of degradation products. Anesthesiology (1997) 0.87
Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d). J Immunol (2001) 0.87
Inactivation of methionine synthetase by nitrous oxide in mice. Anesthesiology (1981) 0.87
Metabolism of compound A by renal cysteine-S-conjugate beta-lyase is not the mechanism of compound A-induced renal injury in the rat. Anesth Analg (1996) 0.87
Unexplained failure of a continuous spinal anesthetic. Anesthesiology (1970) 0.86
Fentanyl augments the blockade of the sympathetic response to incision (MAC-BAR) produced by desflurane and isoflurane: desflurane and isoflurane MAC-BAR without and with fentanyl. Anesthesiology (1998) 0.86
The anesthetic potencies of alkanethiols for rats: relevance to theories of narcosis. Anesth Analg (2000) 0.85
Minimum alveolar anesthetic concentration of fluorinated alkanols in rats: relevance to theories of narcosis. Anesth Analg (1999) 0.85